Application 070257
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | INJECTABLE;INJECTION | 0.4MG/ML | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 0409-1219 | Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hospira, Inc. | ANDA | Current |
| 51662-1385 | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1385 | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |